Bestimmung freier Leichtketten im Serum bei Plasmazelldyskrasien - 10 - 2009 - Heftarchiv - AMT
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities - ScienceDirect
Eintrag - Leistungsverzeichnis Labor Dr. Gärtner
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
Cureus | Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19 | Article
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Selektive Bestimmung der freien Leichtketten im Serum Verbesserung ...
Hämatologie: Kappa-/Lambda-Quotient | Labor Dr. Wisplinghoff
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Detection of oligoclonal IgG kappa and IgG lambda bands in ...
Biomedicines | Free Full-Text | Saliva Free Light Chains in Patients with Neuro-Sjögren
Immunoglobulin light chain - Wikipedia
Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS | PLOS ONE
Cureus | Light Chain Deposition Disease: A Morphological Case Report | Article
kappa/lambda ratios, and viral antibody titres in
Cureus | Biclonal Gammopathy as a Misleading Indicator to Diagnose POEMS Syndrome: An Autopsy Case Report and a Review of the Literature | Article
Biomedicines | Free Full-Text | Saliva Free Light Chains in Patients with Neuro-Sjögren
3.2: Product and Quotient Rule - Ximera
Eintrag - Leistungsverzeichnis Labor Dr. Gärtner
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis | PLOS ONE
Biomedicines | Free Full-Text | Saliva Free Light Chains in Patients with Neuro-Sjögren
IgL-Kette I: Siehe Kappa/Lambda-Quotient M: 1 ml Serum N: Median (2,5. - 97,5. Perz.) 160 (110 - 240) mg/dl T: Nephelometrie
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
